Humulin Injection, Solution
Product Images NDC 0002-8215

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Humulin (NDC 0002-8215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Humulin R100 Ifu 10v1)

An instructional diagram showing a person drawing insulin from a vial into a syringe, with a close-up of the syringe scale marked in units from 0 to 40. The vial is held upside down, and an arrow indicates the upward pulling motion of the syringe plunger.*

FDA Label Image

Figure (Humulin R100 Ifu 11v1)

An instructional illustration showing a hand injecting a syringe into a forearm. The other hand holds a vial, suggesting preparation or administration of an injectable medication.*

FDA Label Image

Figure (Humulin R100 Ifu 12v2)

An anatomical diagram illustrating recommended subcutaneous injection sites for insulin. The front view highlights the abdomen and upper legs, while the back view shows the upper buttocks as preferred areas for injection.*

FDA Label Image

Figure (Humulin R100 Ifu 13v1)

Illustration showing a person injecting a syringe into the abdominal area. This instructional image likely demonstrates subcutaneous injection technique relevant for medications such as Humulin R insulin.*

FDA Label Image

Figure (Humulin R100 Ifu 14v1)

A black-and-white instructional illustration showing a person administering an injection into the abdomen using a syringe. The image emphasizes proper hand placement and needle angle for subcutaneous injection, with an arrow indicating the direction of insertion.*

FDA Label Image

Figure (Humulin R100 Ifu 15v1)

Instructional line drawing demonstrating a hand holding a syringe to inject Humulin R insulin into the abdomen area, indicated by an arrow pointing to the injection site.*

FDA Label Image

Figure (Humulin R100 Ifu 16v1)

An instructional diagram of a syringe labeled with parts including needle shield, needle, plunger tip, syringe body, and plunger. The syringe body is marked with unit measurements up to 100 units. A close-up inset highlights an example dose of 20 units at the plunger tip.*

FDA Label Image

Humulin R100 Ifu 1v3

Humulin R 100 units per mL injection in a clear glass vial with a protective black cap and rubber stopper underneath. The label shows the brand name Humulin R prominently with the strength 100 units per mL (U-100). The product is labeled by Eli Lilly and Company.*

FDA Label Image

Figure (Humulin R100 Ifu 3v1)

An instructional illustration showing a hand holding a vial with the cap being removed by pulling upward. This likely demonstrates the first step in preparing a Humulin R 100 IU/mL insulin vial for use.*

FDA Label Image

Figure (Humulin R100 Ifu 4v1)

An instructional illustration showing a person's hands opening a vial by twisting off the cap. This is likely related to injectable medication preparation, such as for Humulin R 100 IU/mL by Eli Lilly and Company.*

FDA Label Image

Figure (Humulin R100 Ifu 5v1)

An instructional illustration showing how to hold a syringe for drawing liquid medication. The left side depicts two hands holding a syringe vertically with an arrow pointing downward, indicating the direction of liquid flow. The right side shows a close-up of the syringe barrel with graduated markings up to 40 units.*

FDA Label Image

Figure (Humulin R100 Ifu 6v1)

An instructional diagram depicting the use of a syringe needle. It shows one hand holding a vial or container and another hand attaching or inserting the needle into the vial, indicated by an arrow pointing downward toward the vial opening.*

FDA Label Image

Figure (Humulin R100 Ifu 7v1)

An instructional black-and-white line drawing showing a person drawing liquid medication from a vial into a syringe. The image focuses on hands holding the syringe and vial, with an arrow indicating the direction of syringe insertion into the vial.*

FDA Label Image

Figure (Humulin R100 Ifu 8v1)

An instructional illustration showing a hand holding a vial upside down with a syringe needle inserted into it, drawing liquid. Next to it is an image of a syringe with markings from 0 to 40 units, filled to about 40 units.*

FDA Label Image

Figure (Humulin R100 Ifu 9v1)

An instructional illustration showing two hands preparing a syringe by drawing liquid from a vial. The vial is held upside down with one hand while the other hand pulls the plunger of the syringe upward to fill it with medication.*

FDA Label Image

Figure (Humulin R100 Qr)

FDA Label Image

Figure 1 (Humulin R100 Uspi 1v1)

A line graph depicting the glucose infusion rate (mg/min/kg) over time (hours) for Humulin R at a dosage of 0.3 U/kg. The curve rises to a peak around 2 to 3 hours, then gradually declines, showing the pharmacodynamic profile over a 14-hour period.*

FDA Label Image

Humulin R100 Vial Carton Nl093

Packaging label for Humulin R Regular (insulin human) injection 100 units per mL (U-100) by Eli Lilly and Company. The label indicates a 10 mL multiple-dose vial for subcutaneous or intravenous use, with storage instructions and warnings. The label also includes the NDC number 0002-8215-01 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.